Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.63 - $1.07 $79,181 - $134,482
125,685 New
125,685 $86,000
Q4 2023

Feb 14, 2024

BUY
$0.66 - $0.91 $101,510 - $139,961
153,804 New
153,804 $133,000
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.49 $7,119 - $9,471
6,357 Added 21.69%
35,669 $42,000
Q1 2023

May 15, 2023

SELL
$1.19 - $2.19 $581,464 - $1.07 Million
-488,626 Reduced 94.34%
29,312 $43,000
Q4 2022

Feb 14, 2023

BUY
$1.07 - $1.34 $205,508 - $257,365
192,064 Added 58.94%
517,938 $626,000
Q3 2022

Nov 14, 2022

SELL
$1.09 - $1.67 $575,441 - $881,639
-527,928 Reduced 61.83%
325,874 $355,000
Q2 2022

Aug 16, 2022

BUY
$1.13 - $3.69 $168,593 - $550,540
149,198 Added 21.17%
853,802 $1.27 Million
Q1 2022

May 17, 2022

BUY
$2.85 - $3.73 $27,154 - $35,539
9,528 Added 1.37%
704,604 $2.32 Million
Q4 2021

Feb 15, 2022

BUY
$3.24 - $5.18 $355,703 - $568,686
109,785 Added 18.76%
695,076 $2.34 Million
Q3 2021

Nov 16, 2021

SELL
$3.94 - $5.84 $236,463 - $350,493
-60,016 Reduced 9.3%
585,291 $2.99 Million
Q2 2021

Aug 16, 2021

BUY
$4.26 - $6.5 $2.25 Million - $3.44 Million
528,935 Added 454.52%
645,307 $2.83 Million
Q1 2021

May 18, 2021

SELL
$5.03 - $8.8 $1.83 Million - $3.2 Million
-363,409 Reduced 75.74%
116,372 $723,000
Q4 2020

Feb 17, 2021

SELL
$4.04 - $5.31 $461,654 - $606,779
-114,271 Reduced 19.24%
479,781 $2.35 Million
Q3 2020

Nov 17, 2020

SELL
$3.64 - $7.76 $149,538 - $318,796
-41,082 Reduced 6.47%
594,052 $2.5 Million
Q2 2020

Aug 17, 2020

BUY
$4.78 - $8.26 $2.42 Million - $4.18 Million
506,302 Added 392.99%
635,134 $4.4 Million
Q1 2020

May 15, 2020

SELL
$4.0 - $21.53 $1.12 Million - $6.05 Million
-281,196 Reduced 68.58%
128,832 $515,000
Q4 2019

Feb 14, 2020

BUY
$13.94 - $24.12 $5.01 Million - $8.68 Million
359,725 Added 715.12%
410,028 $8.79 Million
Q3 2019

Nov 14, 2019

SELL
$13.89 - $23.16 $528,778 - $881,678
-38,069 Reduced 43.08%
50,303 $762,000
Q2 2019

Aug 15, 2019

SELL
$16.27 - $20.51 $5.68 Million - $7.16 Million
-348,881 Reduced 79.79%
88,372 $1.71 Million
Q1 2019

May 16, 2019

BUY
$12.61 - $22.33 $4.19 Million - $7.42 Million
332,446 Added 317.2%
437,253 $9.08 Million
Q4 2018

Feb 15, 2019

SELL
$12.41 - $22.98 $10.5 Million - $19.4 Million
-842,491 Reduced 88.94%
104,807 $1.43 Million
Q3 2018

Nov 14, 2018

BUY
$2.45 - $16.27 $2.32 Million - $15.4 Million
947,298 New
947,298 $15.4 Million
Q2 2018

Aug 15, 2018

SELL
$2.68 - $3.48 $40,596 - $52,715
-15,148 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$2.99 - $4.44 $11,768 - $17,475
-3,936 Reduced 20.62%
15,148 $46,000
Q4 2017

Feb 15, 2018

BUY
$3.06 - $4.09 $58,397 - $78,053
19,084
19,084 $77,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $214M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.